ACHC — Acadia Healthcare Company, Inc. stock price, charts and financials

QT85Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.67
+1.08+3.53%
OverviewShort InterestFilings
ACHCQT85Acadia Healthcare Company, Inc.·NASDAQ
31.67+3.53%
TA
Loading chart...
Signal & projected range
Short-squeeze setupHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
NHC-6.54%$208.20GRDN-0.69%$40.53BKD-0.97%$14.23OPCH-0.04%$23.69LFST-2.66%$10.26CON-1.83%$31.12ADUS-2.68%$113.66SGRY-2.55%$15.65
Snapshot
Index-P/E-EPS (ttm)-12.45Insider Own10.17%Shs Outstand93.10MPerf Week-3.12%
Market Cap2.95BForward P/E17.38EPS next Y1.82Insider Trans0.00%Shs Float86.19MPerf Month1.87%
Enterprise Value5.34BPEG-EPS next Q0.51Inst Own146.06%Short Float25.29%Perf Quarter14.37%
Income-1.13BP/S0.88EPS this Y112.27%Inst Trans-Short Ratio7.09Perf Half Y139.74%
Sales3.37BP/B1.35EPS next Y19.31%ROA-20.31%Short Interest21.80MPerf YTD123.19%
Book/sh23.54P/C17.24EPS next 5Y18.33%ROE-50.02%52W High35.83 -11.61%Perf Year50.17%
Cash/sh1.84P/FCF-EPS past 3/5Y-ROIC6.69%52W Low11.43 177.08%Perf 3Y-60.12%
Dividend Est.-EV/EBITDA-Sales past 3/5Y8.27% 9.65%Gross Margin35.56%Volatility8.60% 5.66%Perf 5Y-48.47%
Dividend TTM-EV/Sales1.59EPS Y/Y TTM-547.84%Oper. Margin10.06%ATR (14)1.83Perf 10Y-41.55%
Dividend Ex-Date-Quick Ratio1.56Sales Y/Y TTM6.79%Profit Margin-33.44%RSI (14)53.16Recom2.36
Dividend Gr. 3/5Y-Current Ratio1.57EPS Q/Q-54.22%SMA20-1.32%Beta0.63Target Price32.00
Payout0.00%Debt/Eq1.24Sales Q/Q-0.35%SMA5011.75%Rel Volume0.64Prev Close30.59
Employees25,000LT Debt/Eq1.22EarningsNov 04SMA20044.15%Avg Volume3.00MPrice31.67
IPO DateMar 04, 1994Option/ShortYes / YesEPS/Sales Surpr.9.74% 2.56%Net Debt/EBITDA-3.50Volume1,908,201Change3.53%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-30-26ReiteratedBarclaysEqual Weight$25 → $32
Jul-30-26ReiteratedGuggenheimBuy$38 → $39
Jul-20-26ReiteratedGuggenheimBuy$31 → $38
Jul-14-26ReiteratedKeybancOverweight$30 → $40
Jul-09-26ReiteratedUBSBuy$31 → $39
Jun-03-26UpgradeJefferiesHold → Buy$25 → $30
May-27-26ReiteratedKeyBancOverweight$25 → $30
May-04-26ReiteratedGuggenheimBuy$22 → $31
May-04-26ReiteratedRBC CapitalOutperform$17 → $31
May-01-26ReiteratedCantor FitzgeraldNeutral$17 → $30
Latest News
Jul-31-26
Jul-31-2610:00AM
Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Informationprnewswire.com
Jul-30-26
Jul-30-2609:51AM
Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $39Benzinga
Jul-29-26
Jul-29-2608:53PM
Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcriptseekingalpha.com
11:05AM
Acadia Healthcare Q2 Earnings Call Highlightsmarketbeat.com
10:11AM
Acadia Healthcare Q2 Earnings Beat Estimates on Higher Admissionszacks.com
Jul-28-26
Jul-28-2609:01PM
Acadia Healthcare (ACHC) Falls on Soft Guidance Despite Earnings BeatChartMill
07:01PM
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimateszacks.com
04:51PM
Acadia Healthcare Stockholders: Contact Robbins LLP for Information About The Class Action Lawsuit Against ACHCglobenewswire.com
04:05PM
Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidancebusinesswire.com
Jul-27-26
Jul-27-2603:50PM
Acadia Healthcare (NASDAQ: ACHC) Investors: Court Denies Motion to Dismiss Paving Way for Litigation to Proceed; Contact Robbins LLP for Information About Your Rightsbusinesswire.com
Jul-20-26
Jul-20-2608:44AM
Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $38Benzinga
Jul-14-26
Jul-14-2611:19AM
TD Cowen Maintains Buy on Acadia Healthcare Co, Raises Price Target to $36Benzinga
Jul-09-26
Jul-09-2604:15PM
Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Releasebusinesswire.com
03:25PM
UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $39Benzinga
Jul-06-26
Jul-06-2603:27AM
Universal Health Services: From A Cash Trap To A Value TrapSeekingAlpha
Company

Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.

Ownership
Total institutional ownership146.06%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,3683,3133,1542,9292,6102,3142,0902,0083,012
Cost of Goods Sold Incl. D&A2,1692,7292,4422,24610091871,1931,779
Gross Profit1,1985837126832,5102,2242,0038151,234
Selling, General and Administrative Excl. Other6821951901761,5971,4191,312154308
Research and Development
000000000
Other Operating Expense1770004463906910513
Operating Income3403885225074684140662413
Interest Expense151139116827077158187185
Unusual Expense
—————————
Non-Operating Income (Expense)-1,285-1,315-64-450-24-62342-396-396
Net Income Before Taxes-1,096-1,066342-2537427618478-169
Income Taxes272677-10946841257
Consolidated Net Income-1,127-1,103256-22273191-672109-176
Net Income From Continuing Operations-1,123-1,092264-162802081435357
Net Income-1,127-1,103256-22273191-672109-176
EPS (Recurring)-12.45-12.162.79-0.243.052.15-7.651.24-2.01
EPS (Basic, Before Extraordinaries)-12.45-12.162.79-0.243.052.15-7.651.24-2.01
EPS (Diluted)-12.45-12.162.78-0.242.982.10-7.651.24-2.01
EBITDA-684-738608189562459437402386
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio——14.26—27.6228.90—26.79—
Price To Sales Ratio0.860.391.162.422.842.332.121.460.74
Gross Margin35.5717.6022.5723.3296.1796.1195.8440.5940.97
Operating Margin10.1011.7116.5517.3117.9317.890.0032.9713.71
Net Margin-33.46-33.298.12-0.7510.468.25-32.155.43-5.84
Shares Outstanding919192919089888887
Market Capitalization2,8821,2913,6487,0767,4095,4024,4232,9232,237
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$39.20$31.42$23.64$15.87$8.09● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Miquelon Wade DDirectorMar 05 '24Sale85.392,203188,11446,074Mar 06
Gregg Vicky BDirectorMar 04 '24Sale85.562,500213,90026,851Mar 06
OSTEEN DEBRA KDirectorDec 13 '23Sale77.6735,0002,718,450675,833Dec 14
OSTEEN DEBRA KDirectorDec 12 '23Sale76.238,000609,840710,833Dec 14
Hollinsworth John S.EVP of OperationsNov 14 '23Sale74.0192,5006,846,30084,630Nov 16
Hollinsworth John S.EVP of OperationsNov 10 '23Sale73.0020,0001,460,000177,130Nov 13
Hollinsworth John S.EVP of OperationsNov 08 '23Sale74.5012,500931,250197,130Nov 13
OSTEEN DEBRA KDirectorNov 08 '23Sale74.2115,0001,113,150718,833Nov 13
GRIECO WILLIAMDirectorSep 07 '22Sale82.545,000412,70073,811Sep 09
Hollinsworth John S.EVP of OperationsAug 04 '22Sale80.6810,780869,73080,559Aug 08
Duckworth David M.Chief Financial OfficerAug 04 '22Sale80.6326,9212,170,67799,263Aug 08
Howard Christopher LEVP, GC and SecretaryAug 04 '22Option Exercise50.7512,274622,906169,804Aug 08
Howard Christopher LEVP, GC and SecretaryAug 04 '22Sale81.6020,6571,685,706149,147Aug 08
Petrie William Mdirector:Jul 29 '22Sale83.426,000500,52031,769Aug 02
Hollinsworth John S.EVP of OperationsJun 14 '21Sale66.315,000331,55056,275Jun 16
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.